Stem Cell Treatments - Google News: Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the ... - Sacramento Bee

0 Comments
Stem Cell Treatments - Google News
Google News
Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the ... - Sacramento Bee
Nov 27th 2012, 13:23


Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the ...
Sacramento Bee
ProHema is an innovative cord blood-derived cell therapy containing pharmacologically-modulated hematopoietic stem cells (HSCs). ProHema is produced through a proprietary, two-hour, ex vivo cell modulation process that results in rapid activation of ...

and more »
You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions


About Post Author

Morbi leo risus, porta ac consectetur ac, vestibulum at eros. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus.

You may also like

Tidak ada komentar: